September 3, twenty-five patient organizations working in the field of HIV response in Russia published an open letter to Gilead Sciences, asking the pharmaceutical company to disclaim patent rights for the combination of tenofovir and emtricitabine, marketed under the tradename Truvada.
ITPCru team is glad to present their report on ARVs procurement monitoring in Russia in 2018.
ITPCru is proud to present its first regional report on procurement and provision of antiretroviral drugs in 7 countries of Eastern Europe and Central Asia in 2017. The report is based on a series of national reports implemented by patient organizations in the respective countries (Armenia, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Ukraine).
Treatment Preparedness Coalition in Eastern Europe and Central Asia (ITPCru) expresses its deep concern over the situation in Kazakhstan where hundreds of people for several weeks have been facing stock-outs of life-saving antiretroviral treatment.
ITPCru has published their new report about the results of ARV drugs procurement monitoring in 2017.
The Association of Clinical Trials Organizations published their newsletter “Russian clinical trials market in 2012-2017”. A part about HCV, HIV and TB drugs is included.
We would like to present you our new poster in support of people with HIV who were recently diagnosed. It is called “Good news for people with HIV”. The poster contains separate blocks of information about differents aspects, for example, about a fact that effective treatment exists, people don’t die of HIV anymore, a lifespan is not limited by HIV, HIV
